MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Approaches to understanding the role of STN in the development of ICD in Parkinson’s disease

    A. Buniak, V. Bayarchyk, A. Mikitchuk (Minsk, Belarus)

    Objective: The aim of this study was to identify the features of subthalamic tracts in PD patients with ICD. Background: Recurrent negative feedback loops from…
  • 2025 International Congress

    Cognitive Decline in Parkinson’s Disease: A Decade-Long Registry Analysis of Prevalence and Risk Factors

    L. Ge, K. Asai, K. Ogawa, K. Ikenaka, Y. Kimura, H. Mochizuki (Suita, Japan)

    Objective: This study aims to identify predictors of cognitive decline in cognitively normal Parkinson’s disease patients by analyzing the 10 years-long PD registry. Background: Cognitive…
  • 2025 International Congress

    Co-Occurrence of DAT Scan, Amyloid PET Scan, and Alzheimer’s Genetic Screening Abnormalities in Patient with Early-Onset Neurocognitive Decline: A Case Report

    A. Mason, R. Payne, N. Shneyder, E. Baldinger (Tampa, USA)

    Objective: The presented case report aims to show the possible overlap between causes of neurocognitive decline and the importance of considering comorbidities when discussing anti-amyloid monoclonal…
  • 2025 International Congress

    Impact of Genetically Defined Ancestry on Progression of Idiopathic Parkinson’s Disease.

    J. Frost, S. Gray-Rodriguez, L. Wu, M. Lawton, Y. Ben-Shlomo, M. Hu, D. Grosset, R. Real, H. Morris (London, United Kingdom)

    Objective: To assess the impact of genetically defined ancestry on progression of idiopathic Parkinson's Disease and evaluate the contribution of known genetic variation on any…
  • 2025 International Congress

    Quality of Life Impact on Adults with Parkinson’s Disease Experiencing Morning Akinesia: Real-World Observational Findings

    O. de Fabregues, K. Onuk, C. Yan, P. Kukreja, L. Bergmann, S. Colman, D. Falconer, J. Sarna, F. Ory-Magne, L. Defebvre, V. Fung (Barcelona, Spain)

    Objective: To compare the quality of life (QoL) in Parkinson’s Disease (PD) patients with and without morning akinesia (MA) in those using oral medications only…
  • 2025 International Congress

    Early Indicators of Alpha-synuclein Aggregation: Can Autonomic and Cognitive Markers Predict Prodromal Parkinson’s Disease?

    B. Kansu, C. Mattjie, R. Ravazio, M. Patyjewicz, A. Noyce, C. Simonet (London, United Kingdom)

    Objective: To develop a model that predicts alpha synuclein (a-syn) status of patients at risk of Parkinson’s disease (PD) using non-motor and cognitive tests that…
  • 2025 International Congress

    Real-life experience with continuous subcutaneous foslevodopa/foscarbidopa infusion in advanced stage of Parkinson’s disease at Villa Margherita

    G. Nordera, N. Bonetto, F. Perini (Vicenza, Italy)

    Objective: We present the results of our case series with continuous subcutaneous infusion (CSCI) produodopa in 2024, focusing on tolerability and efficacy, in line with…
  • 2025 International Congress

    Muscle Interactions during Gait in People with Parkinson’s Disease

    D. Tosatto, D. Bonacina, F. Fumagalli, A. Alessandro, C. Perin, D. Piscitelli (Milano, Italy)

    Objective: To study modulation and asymmetry in lower limb muscles in individuals with Parkinson’s Disease (PD), compared to healthy controls (HC). Background: Walking disorders are…
  • 2025 International Congress

    Examining the Influence of Task Complexity on Dual Task Performance in Parkinson’s disease.

    S. Conklin, P. Hill, L. Schwarz, YF. Chiu, J. Longhurst (Saint Louis, USA)

    Objective: This study aimed to examine the impact of walking task complexity and cognitive speaking task (CST) condition on dual-task effects (DTE) in people with…
  • 2025 International Congress

    Health Disparity in Rural Southern California

    A. Maleki, M. Tar, D. Tar (moreno valley, USA)

    Objective: To analyze the demographic and clinical characteristics of hispanic patients with Parkinson's disease in rural southern California Background: Parkinson’s disease (PD) is the second…
  • « Previous Page
  • 1
  • …
  • 89
  • 90
  • 91
  • 92
  • 93
  • …
  • 181
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley